To initiate the AUC process, patient scenarios that are common in clinical practice were drafted, along with assumptions and definitions for those scenarios. The scenarios were created using published guidelines, trial data, and expert opinions from within the field of peripheral artery disease. The writing group developed 45 clinical scenarios with up to 6 intervention options per scenario and categorized them into 6 general sections. A separate, independent rating panel evaluated each indication using a scoring scale from 1 to 9, thereby designating each indication as "Appropriate" (score of 7 to 9), "May Be Appropriate" (score of 4 to 6), or "Rarely Appropriate"
(score of 1 to 3).
Throughout the scenarios, emphasis was placed on adhering to and exhausting medical therapy to achieve maximal benefit in those situations in which symptom management was desired or incidental disease was discovered. However, situations arise in which medical therapy is insufficient, and identifying a suitable revascularization strategy is necessary. After considering factors such as symptom burden, anatomic distribution, and The purpose of this guidance document is neither to detail every clinical situation nor to describe the use of every device used in the treatment of PAD. Rather, the goal is to provide generalized guidance into the use of these devices and techniques, while understanding that each clinical situation is unique, with physicians using their best judgment and the available evidence base to craft the most beneficial approach for the patient. In all cases, it is assumed that guideline-directed medical therapy should be applied first. Moreover, in determining the appropriate use of the described treatments, the rating panel was instructed to not compare the treatment options with each other. Although it is difficult to avoid comparing "scores" for each treatment in the patient scenarios, each treatment option should be considered on its own merits and not ranked against the other options.
This is necessary owing to the diffusion of expertise and availability of techniques and tools, which varies across the range of situations and settings in which care is provided to patients with PAD.
METHODS
To begin the AUC process, a multidisciplinary writing The rating panelists were then tasked with scoring the clinical scenarios from 1 through 9, with 1 to 3 classified as "Rarely Appropriate care," 4 to 6 as "May Be Appropriate care," and 7 to 9 as "Appropriate care." Panelists conducted this scoring via an electronic survey platform, and the median score from the 13 panelists was calculated for each scenario. Next, the panelists, several writing group representatives, and a moderator came together for an in- 4. In this document, the term "family history" refers to first-degree relatives only. 31. Popliteal artery aneurysmal disease is not included.
32. Common femoral artery disease is not included.
33. The SFA extends from its ostium after bifurcation of the common femoral artery to the adductor canal.
34. The below-the-knee segment extends from the origin of the anterior tibial artery to the pedal arch. 48. For the purposes of this document, focal restenosis is defined as a lesion length #50 mm, whereas diffuse restenosis is defined as >50 mm (14) . No consistent definition is currently found in the literature. gangrene, a nonhealing ischemic ulcer, or rest pain. The ultrasonographic criterion is defined as a 2.5-fold increase in the peak systolic velocity in the narrowed segment compared with the adjacent proximal segment (16, 17) . In clinical practice, the recurrence of symptoms, a 20% decline in ankle-brachial index, and a >3-fold increase in peak systolic velocity ratio are combined to guide the decision regarding reintervention (17) .
The primary impetus behind surveillance of in-stent restenosis is that an occluded stent is more difficult to restore. However, no randomized studies have been conducted to determine whether this approach is clini- panelists rather than the original 13 (1 panelist passed away during the rerating process).
Section 4 Asymptomatic Artery Disease

Section 4 Results and Discussion
The appropriate use recommendations for asymptom- 
Section 5 Results and Discussion
The clinical scenarios in Section 5 specifically address 3 broad treatment options for the disease states listed.
Given the variability in the lesion lengths that span mul- 
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n Length <100 mm M (6) A (7) A (7) A (7) A (7) M (6) 33. n Length $100 mm M (5) M (5) A (7) A (7) A (7) 
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n Length <100 mm M (4) A (7) M (4) M (5) A (7) R (3)
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Section 6 Results and Discussion
The indications in Section 6 specifically address previously treated segments that have restenosed or The procedure may be recognized to be effective in isolated situations but is not generally used for these 
Use of AUC to Improve Care
The writing group foresees several important applications of these AUC for both clinicians and patients. The most obvious use of this document will be to support the clinical decision making of a physician as to the appropriateness of care that they deliver to an individual patient. It is important to acknowledge that an Appropriate rating in this document should not be misconstrued as a mandate to perform a specific intervention in every patient that meets the indications described herein.
Rather, it should be interpreted as something that would be reasonable to do if the intervention performed could benefit the patient.
It is also important to note that a Rarely Appropriate rating should not be misinterpreted as denoting an indication in which an intervention should never be performed. This category was entitled "Inappropriate" 
CONCLUSION
This AUC report provides a guide for clinicians in deter- 
